A Clinical Study on the Effectiveness of Kasamarda Root Paste with and without Navaka Decoction in Managing Vicharchika (Atopic Dermatitis)

A Comparative Clinical Study To Evaluate The Efficacy Of Kasamard Mool Lepa Externally With And Without Navak Kashaya Internally In Cases Of Vicharchika W.S.R To Atopic Dermatitis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085994

Enrollment

Registered

2025-04-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient willing for trial will first and foremost criteria irrespective of gender, occupation, religion, and economical barrier. 2) Patient of Vicharchika having essential criteria with or without non-essential criteria selected for the clinical trial. 3) Patient between age group above 16 and below 65 years. 4) Patient having EASI SCORE between the range of 0.1- 21.1. 5) Known cases of eczema.

Exclusion criteria

Exclusion criteria: 1) Patients below the age of 16 years and more than 65 years were excluded. 2) Patients of Vicharchika having secondary infections. 3) Patients with uncontrolled diabetes mellitus, Hypertension. 4)Patient having EASI SCORE Greater than 21.1 5)pregnant or lactating women. 6) Patients who have history of acute coronary syndrome, myocardial infarction, stroke, or severe arrhythmia and any serious liver, kidney disorders in the last 6 months.

Design outcomes

Primary

Measure	Time frame
1. To assess the efficacy of trial drug Kasamard mool lepa alone and Navak Kashaya along with kasamard mool lepa will be administered in cases of Vicharchika for 3 months and efficacy of the drug will be observed, assessed, and related data will be collected, constructed, and analysed. 2. To compare the efficacy of trial drug in both group therapeutic data s will be analysed statistically.Timepoint: 15th Day,30th Day,45th Day,60th Day,75th Day,90th Day and 30 days after the trial is completed.	—

Measure

Time frame

1. To assess the efficacy of trial drug Kasamard mool lepa alone and Navak Kashaya along with kasamard mool lepa will be administered in cases of Vicharchika for 3 months and efficacy of the drug will be observed, assessed, and related data will be collected, constructed, and analysed. 2. To compare the efficacy of trial drug in both group therapeutic data s will be analysed statistically.Timepoint: 15th Day,30th Day,45th Day,60th Day,75th Day,90th Day and 30 days after the trial is completed.

—

Secondary

Measure	Time frame
1.To assess safety of trial drug & any adverse effect. 2. To assess the benefit of Sthanic prayoga of lepa. 3.To assess the effectiveness of trial drug in improving the quality of life in patients of Vicharchika. 4.To observe the disease clinically during the follow up period with & without drug.Timepoint: 15th Day,30th Day,45th Day,60th Day,75th Day,90th Day & 30 days after the trial is completed.	—

Measure

Time frame

1.To assess safety of trial drug & any adverse effect. 2. To assess the benefit of Sthanic prayoga of lepa. 3.To assess the effectiveness of trial drug in improving the quality of life in patients of Vicharchika. 4.To observe the disease clinically during the follow up period with & without drug.Timepoint: 15th Day,30th Day,45th Day,60th Day,75th Day,90th Day & 30 days after the trial is completed.

—

Countries

India

Contacts

Public ContactDr Gurmeet Ram

State Ayurvedic College and Hospital Lucknow

gurmeet.dr70@gmail.com9412360556

Outcome results